BR112018006850A2 - método para purificação de derivado de benzopirano, forma de cristal do mesmo e método para preparação de forma de cristal - Google Patents
método para purificação de derivado de benzopirano, forma de cristal do mesmo e método para preparação de forma de cristalInfo
- Publication number
- BR112018006850A2 BR112018006850A2 BR112018006850-0A BR112018006850A BR112018006850A2 BR 112018006850 A2 BR112018006850 A2 BR 112018006850A2 BR 112018006850 A BR112018006850 A BR 112018006850A BR 112018006850 A2 BR112018006850 A2 BR 112018006850A2
- Authority
- BR
- Brazil
- Prior art keywords
- crystal form
- purifying
- amino
- preparing
- benzopyran derivative
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000013078 crystal Chemical group 0.000 title 2
- 150000001562 benzopyrans Chemical group 0.000 title 1
- -1 1h-imidazol-2-ylmethyl Chemical group 0.000 abstract 3
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Abstract
a presente invenção fornece um processo para purificação de (2r,3r,4s)-6-amino-4-[n-(4-clorofenil)-n-(1h-imidazol-2-ilmetil)amino]-3-hidróxi-2-metil-2-dimetoximetil-3,4-dihidro-2h-1-benzopirano, que compreende a conversão de um (2r,3r,4s)-6-amino-4-[n-(4-clorofenil)-n-(1h-imidazol-2-ilmetil)amino]-3-hidróxi-2-metil-2-dimetoximetil-3,4-dihidro-2h-1-benzopirano amorfo em uma forma cristalina do mesmo. e ainda, a presente invenção fornece uma nova forma cristalina de (2r,3r,4s)-6-amino-4-[n-(4-clorofenil)-n-(1h-imidazol-2-ilmetil)amino]-3-hidróxi-2-metil-2-dimetoximetil-3,4-dihidro-2h-1-benzopirano e processos para preparação da mesma.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2015-0167238 | 2015-11-27 | ||
| KR1020150167238A KR102484846B1 (ko) | 2015-11-27 | 2015-11-27 | 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법 |
| PCT/KR2016/013585 WO2017090991A1 (ko) | 2015-11-27 | 2016-11-24 | 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112018006850A2 true BR112018006850A2 (pt) | 2018-12-11 |
| BR112018006850B1 BR112018006850B1 (pt) | 2024-02-06 |
Family
ID=58764306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112018006850-0A BR112018006850B1 (pt) | 2015-11-27 | 2016-11-24 | Forma cristalina a de composto e processos para preparação da mesma |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10487074B2 (pt) |
| EP (1) | EP3381914B1 (pt) |
| JP (1) | JP6768065B2 (pt) |
| KR (1) | KR102484846B1 (pt) |
| CN (2) | CN113754643A (pt) |
| AU (1) | AU2016361026B2 (pt) |
| BR (1) | BR112018006850B1 (pt) |
| CA (1) | CA3001547C (pt) |
| DK (1) | DK3381914T3 (pt) |
| ES (1) | ES2861062T3 (pt) |
| HU (1) | HUE053626T2 (pt) |
| PL (1) | PL3381914T3 (pt) |
| PT (1) | PT3381914T (pt) |
| RU (1) | RU2729074C2 (pt) |
| WO (1) | WO2017090991A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102129159B1 (ko) * | 2017-09-15 | 2020-07-01 | 주식회사 엘지화학 | 저색수 카바졸 화합물의 제조방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3447170A1 (de) * | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| US5837702A (en) * | 1993-10-07 | 1998-11-17 | Bristol-Myers Squibb Co. | 4-arylamino-benzopyran and related compounds |
| US5629429A (en) * | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| US7414068B2 (en) * | 2002-04-10 | 2008-08-19 | Dongbu Hannong Chemical Co., Ltd. | Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| KR100492252B1 (ko) * | 2002-08-09 | 2005-05-30 | 한국화학연구원 | 이미다졸을 포함하는 이차아민으로 치환된 벤조피란유도체 및 그의 제조방법 |
| ATE490257T1 (de) | 2006-08-14 | 2010-12-15 | Sicor Inc | Kristalline formen von pemetrexed-disäure und herstellungsverfahren dafür |
| EP2318411A2 (en) | 2008-07-03 | 2011-05-11 | Ratiopharm GmbH | Crystalline salts of sitagliptin |
| US20130261142A1 (en) * | 2010-12-15 | 2013-10-03 | Hung-Cheng Lai | Compounds used for treating cancer and the use thereof |
| US20140018402A1 (en) * | 2011-03-30 | 2014-01-16 | Catholic University Industry Academic Cooperation Foundation | Pharmaceutical composition for preventing or treating macular degeneration |
| KR101499329B1 (ko) | 2013-06-17 | 2015-03-06 | 주식회사 대웅제약 | (2-(3,4-다이메톡시페닐)-5-(3-메톡시프로필)벤조퓨란)의결정형 및 이의 제조방법 |
-
2015
- 2015-11-27 KR KR1020150167238A patent/KR102484846B1/ko active IP Right Grant
-
2016
- 2016-11-24 PL PL16868887T patent/PL3381914T3/pl unknown
- 2016-11-24 RU RU2018122936A patent/RU2729074C2/ru active
- 2016-11-24 JP JP2018527768A patent/JP6768065B2/ja active Active
- 2016-11-24 EP EP16868887.7A patent/EP3381914B1/en active Active
- 2016-11-24 HU HUE16868887A patent/HUE053626T2/hu unknown
- 2016-11-24 BR BR112018006850-0A patent/BR112018006850B1/pt active IP Right Grant
- 2016-11-24 US US15/779,236 patent/US10487074B2/en active Active
- 2016-11-24 DK DK16868887.7T patent/DK3381914T3/da active
- 2016-11-24 CN CN202111023748.XA patent/CN113754643A/zh active Pending
- 2016-11-24 AU AU2016361026A patent/AU2016361026B2/en active Active
- 2016-11-24 PT PT168688877T patent/PT3381914T/pt unknown
- 2016-11-24 WO PCT/KR2016/013585 patent/WO2017090991A1/ko active Application Filing
- 2016-11-24 ES ES16868887T patent/ES2861062T3/es active Active
- 2016-11-24 CA CA3001547A patent/CA3001547C/en active Active
- 2016-11-24 CN CN201680067212.9A patent/CN108290873A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3381914A4 (en) | 2019-05-08 |
| US20190248768A1 (en) | 2019-08-15 |
| PT3381914T (pt) | 2021-03-15 |
| CN113754643A (zh) | 2021-12-07 |
| ES2861062T3 (es) | 2021-10-05 |
| KR20170061980A (ko) | 2017-06-07 |
| CN108290873A (zh) | 2018-07-17 |
| US10487074B2 (en) | 2019-11-26 |
| RU2018122936A3 (pt) | 2020-01-21 |
| EP3381914A1 (en) | 2018-10-03 |
| CA3001547C (en) | 2023-08-22 |
| WO2017090991A1 (ko) | 2017-06-01 |
| KR102484846B1 (ko) | 2023-01-05 |
| EP3381914B1 (en) | 2020-12-23 |
| RU2729074C2 (ru) | 2020-08-04 |
| CA3001547A1 (en) | 2017-06-01 |
| JP2018535240A (ja) | 2018-11-29 |
| BR112018006850B1 (pt) | 2024-02-06 |
| HUE053626T2 (hu) | 2021-07-28 |
| RU2018122936A (ru) | 2019-12-31 |
| DK3381914T3 (da) | 2021-03-22 |
| PL3381914T3 (pl) | 2021-07-05 |
| JP6768065B2 (ja) | 2020-10-14 |
| AU2016361026B2 (en) | 2020-06-11 |
| AU2016361026A1 (en) | 2018-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22051489A (es) | Compuestos inhibidores de metaloenzimas | |
| CL2018000596A1 (es) | Nuevos compuestos bicíclicos como inhibidores de la atx | |
| PT3455213T (pt) | Método para purificar compostos canabinoides através de cromatografia em leito móvel simulado | |
| CL2018001226A1 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
| BR112017007636A2 (pt) | métodos para a preparação de ribosídeos | |
| BR112019002357A2 (pt) | purificação de matéria-prima por tratamento térmico | |
| BR112016029318A2 (pt) | tratamento de mielomas | |
| BR112016010454A2 (pt) | métodos para tratar uma taupatia | |
| BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
| BR112014010460A2 (pt) | composto, composição farmacêutica, processo para produzir uma composição farmacêutica, método de tratamento, kit e uso de uma composição farmacêutica | |
| BR112018004246A2 (pt) | combinação que compreende oligonucleotídeos imunoestimulantes | |
| CL2017002719A1 (es) | Imidazopirazinonas como inhibidores de pde1 | |
| BR112018075667A2 (pt) | cromatografia de interação hidrofóbica para purificação de oligonucleotídeos | |
| CY1123267T1 (el) | Κρυσταλλικες μορφες 2-(tpit-boytyλamino)-4-((1r,3r,4r)-3-yδpoξy-4-μεθυλοκυκλοεξυλαμινο)-πυριμιδινο-5-καρβοξαμιδιου | |
| CR20140553A (es) | Compuestos de fenoxietil piperidina | |
| BR112018012678A2 (pt) | processo para purificação de copolímeros em bloco de poliéter. | |
| CL2015002837A1 (es) | Compuestos de piridinilpirazoloquinolina. | |
| BR112015002493A2 (pt) | composto , composição farmacêutica , método para o tratamento do câncer , processo para a preparação de uma composição farmacêutica , conjunto , utilização de um composto e invenção. | |
| BR112017006552A2 (pt) | composições e métodos para inibir a atividade biológica de biomoléculas solúveis | |
| UY36602A (es) | Variantes de protoxina-ii y métodos de uso | |
| IL282035A (en) | Method for purifying cannabinoids | |
| ES2600827A8 (es) | Formas cristalinas de bilastina y procedimientos para su preparación | |
| BR112018011085A2 (pt) | composições farmacêuticas contendo doravirina, fumarato de tenofovir desoproxila e lamivudina | |
| BR112015006056A2 (pt) | métodos para tratar hcv | |
| BR112016013946A8 (pt) | quinazolin-thf-aminas como inibidores de pde1, composição farmacêutica que os compreende, processo para preparação da referida composição farmacêutica, bem como uso dos composto e kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/11/2016, OBSERVADAS AS CONDICOES LEGAIS |